518 Stock Overview
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Jiangsu Sihuan Bioengineering Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.13 |
| 52 Week High | CN¥4.57 |
| 52 Week Low | CN¥1.72 |
| Beta | 0.55 |
| 1 Month Change | -25.26% |
| 3 Month Change | -31.07% |
| 1 Year Change | -25.78% |
| 3 Year Change | -47.79% |
| 5 Year Change | -48.55% |
| Change since IPO | 235.21% |
Recent News & Updates
More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%
Apr 17
Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Investors Are Less Pessimistic Than Expected
Feb 26Shareholder Returns
| 518 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -10.5% | -1.9% | -0.2% |
| 1Y | -25.8% | -26.9% | -17.8% |
Return vs Industry: 000518 exceeded the CN Biotechs industry which returned -29.3% over the past year.
Return vs Market: 000518 underperformed the CN Market which returned -21.1% over the past year.
Price Volatility
| 518 volatility | |
|---|---|
| 518 Average Weekly Movement | 9.5% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 000518's share price has been volatile over the past 3 months.
Volatility Over Time: 000518's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 250 | Yu Guo | www.000518shsw.com/shsw |
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects.
Jiangsu Sihuan Bioengineering Co., Ltd Fundamentals Summary
| 518 fundamental statistics | |
|---|---|
| Market cap | CN¥2.19b |
| Earnings (TTM) | -CN¥56.75m |
| Revenue (TTM) | CN¥253.46m |
8.7x
P/S Ratio-38.6x
P/E RatioIs 518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 518 income statement (TTM) | |
|---|---|
| Revenue | CN¥253.46m |
| Cost of Revenue | CN¥80.53m |
| Gross Profit | CN¥172.92m |
| Other Expenses | CN¥229.68m |
| Earnings | -CN¥56.75m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -0.055 |
| Gross Margin | 68.23% |
| Net Profit Margin | -22.39% |
| Debt/Equity Ratio | 2.9% |
How did 518 perform over the long term?
See historical performance and comparison